This federal contract award, identified as SPE2DB20D1004|SPE2DB24FNCLK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 36,000 unit capsules of the drug Creon DR. The firm-fixed-price delivery order has a ceiling value of $2,559.15 and is set to be completed by September 13, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office division holds this contract, which is likely part of the company's extensive Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.
Generated 12/12/24, 9:22 AM